Times of India

Starbucks ends employee coverage for these medicines amid rising US health costs

Starbucks ends employee coverage for these medicines amid rising US health costsWorldPing

Starbucks will cease covering GLP-1 weight-loss drugs for employees starting October. This decision reflects rising costs and a broader employer trend in benefits. GLP-1 drugs, initially for diabetes, are now popular for obesity treatment.

This is a short WorldPing brief. The full report was published by Times of India.

Read the full report at Times of India

Related news

UK manufacturers face rising hacking risk as survey shows 30% were hit last yearWorldPing
The Guardian

UK manufacturers face rising hacking risk as survey shows 30% were hit last year

Big companies describe being under constant threat but only half have a plan in place to respond to an attack Nearly a third of British manufacturers have been hit by a cyber-attack on them or a company in their supply chain, according to a survey th…

Brief by WorldPing · Original reporting by The Guardian